Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Inventory: 2016-2025

Historic Inventory for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $38.1 million.

  • Collegium Pharmaceutical's Inventory rose 0.05% to $38.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 0.05%. This contributed to the annual value of $35.6 million for FY2024, which is 9.98% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Inventory of $38.1 million as of Q3 2025, which was down 0.25% from $38.1 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Inventory ranged from a high of $80.1 million in Q1 2022 and a low of $15.5 million during Q1 2021.
  • For the 3-year period, Collegium Pharmaceutical's Inventory averaged around $33.8 million, with its median value being $34.1 million (2023).
  • Its Inventory has fluctuated over the past 5 years, first soared by 417.14% in 2022, then plummeted by 66.53% in 2023.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Inventory stood at $17.4 million in 2021, then surged by 167.34% to $46.5 million in 2022, then plummeted by 30.47% to $32.3 million in 2023, then increased by 9.98% to $35.6 million in 2024, then grew by 0.05% to $38.1 million in 2025.
  • Its Inventory was $38.1 million in Q3 2025, compared to $38.1 million in Q2 2025 and $37.2 million in Q1 2025.